Payers want to see the actual clinical condition
Introduction: Introduction: AOD-9604 is a synthetic peptide fragment of human growth hormone (hGH 177191) engineered to replicate hGHs fat-metabolism effects without altering IGF-1 or glucose levels. In preclinical research, it promoted lipolysis (fat breakdown) and reduced lipogenesis (fat storage) through receptor-independent mechanisms. AOD-9604 Fast Facts Class: Synthetic hGH fragment analog (Tyr-hGH 177191) Intended purpose: Stimulate fat metabolism while avoiding hGHs growth or glucose effects Mechanism: Increases fat oxidation, enhances lipolysis, suppresses lipogenesis Distinct from hGH: Does not activate the growth hormone receptor or raise IGF-1 Development stage: Completed Phase II trials
Other common, and often minor, side effects can include headache, fatigue, dizziness, irritation around the injection site, and general lack of energy
It may also be used to treat other conditions, such as pernicious anemia, vitamin B12 malabsorption, and certain types of nerve pain
Patients interested in GLP-1 weight loss treatments should discuss with their provider whether combining these medications with lipotropic injections is appropriate for their individual health profile and goals
Pros: combines hydration, B12, and other vitamins in one session, useful when you are coming in for general wellness rather than B12 alone